Nav: Home

High-risk medical devices: IQWiG sees no potential in 6 of 8 cases

March 22, 2017

The German Institute for Quality and Efficiency in Health Care (IQWiG) has completed 8 assessments of the benefit and potential of new treatment methods with high-risk class medical devices. Besides targeted lung denervation in patients with chronic obstructive pulmonary disease (COPD), a further method was investigated for 7 other indications: Ultrasound-guided high-intensity focused ultrasound (USgHIFU) is to be used to treat uterine endometriosis and fibroids, as well as pancreatic tumours, primary and secondary liver tumours, and primary and secondary bone malignancies if patients are not eligible for surgery.

The Institute could only recognize a so-called "potential of a required treatment alternative" for 2 therapeutic indications, namely uterine fibroids and primary liver tumours. No potential could be inferred for the other 6 indications from the documents submitted.

"Potential of a required treatment alternative" investigated

The assessment of new treatment methods largely based on high-risk class medical devices was introduced in 2015 with the German Statutory Health Insurance Act to Promote Health Care (GKV-VSG) as §137h in Social Code Book (SGB) V. In 2016 it was specified by corresponding rules of procedure of the Federal Joint Committee (G-BA).

This assessment procedure is triggered by a hospital submitting a request for additional compensation for the remuneration of healthcare services to the Institute for the Fee System in the Hospital (InEK). Such a request for a new examination and treatment method is called an "NUB request" ("Neue Untersuchungs- und Behandlungsmethoden"). Together with the NUB request, the hospital also submits the available scientific evidence on the new method to the G-BA.

If the method is largely based on the use of high-risk class medical devices and represents a new theoretical-scientific concept, the G-BA must determine if the benefit of the method is proven or whether it at least "offers the potential of a required treatment alternative". This means that patients might possibly get well faster or the new method might be less burdensome than those methods currently available. For this purpose, the G-BA commissions IQWiG to assess the scientific evidence submitted by the hospital.

Questionable applicability of results between indications

From IQWiG's point of view, a potential resulting from the documents on an indication cannot necessarily be applied to other indications where the same method is used. For example, liver tumours are something completely different from benign uterine growths or malignant bone tumours. Ultrasound therapy that can destroy a growth in one indication without damaging the adjacent tissue could be ineffective in another indication or cause harm.

Plausibility alone is insufficient

Likewise, a plausible mode of action is insufficient to attribute a potential to the method. According to the explanation of the law "a potential for the necessity of a method can, for example, arise from the fact that, because of its mode of action and the evidence so far available, it is associated with the expectation that it can replace other methods that are more elaborate and more invasive for patients or unsuccessful in certain patients."

Sparse information

Such evidence is available for both indications where IQWiG sees a potential. Positive results on the treatment of uterine fibroids were available from a non-randomized and a randomized controlled trial; 2 comparative studies on primary liver cancer also indicated positive effects. In both cases, a testing study is basically possible to obtain the necessary information for a benefit assessment.

In contrast, for the other 6 indications, the evidence submitted largely consisted of case series that provided hardly any information on the potential benefit or harm of the methods - especially as no data were submitted on the course of disease without the new method. For one indication, no data were provided at all.

"Obligation to deliver" instead of "obligation to collect"

In assessments according to §137h, IQWiG itself does not search for study data; rather, the requesting hospitals must demonstrate that a potential exists by means of comprehensible data. The Institute's Director Jürgen Windeler emphasizes: "If they do that, their chances are good. The 2 cases in which we attributed a potential to ultrasound-guided high-intensity focused ultrasound show that one can also reach a preliminary positive result on the basis of a few studies - even if the data are insufficient to already consider the benefit to be proven. However, it is out of the question that, to provide a first evaluation of such methods, the Institute has an "obligation to collect" and may possibly have to exhaustively search the international literature to prove that a method has no potential."

Was does evidence-based medicine mean and what is its purpose?

Jürgen Windeler is concerned that only sparse evidence is available for methods that evidently are already being used in health care: "Apparently one must again and again justify the standards of evidence-based medicine, otherwise they are called into question as being detrimental to innovation. We do not insist on well planned, properly conducted, sufficiently large, transparently documented, low risk-of-bias studies because of bureaucratic nitpicking: The benefit and harm for patients simply cannot be assessed in any other way - and we are not talking about plasters and nappies here, but about high-risk devices where nerves are clipped irreversibly or organs are treated with very high-energy ultrasound."
English-language executive summaries of the assessments of potential will be available soon. If you would like to be informed when they are available, please send an e-mail to

Institute for Quality and Efficiency in Health Care

Related Health Care Articles:

Care management program reduced health care costs in Partners Pioneer ACO
Pesearchers at Partners HealthCare published a study showing that Partners Pioneer ACO not only reduces spending growth, but does this by reducing avoidable hospitalizations for patients with elevated but modifiable risks.
Health care leaders predict patients will lose under President Trump's health care plans
According to a newly released NEJM Catalyst Insights Report, health care executives and industry insiders expect patients -- more than any other stakeholder -- to be the big losers of any comprehensive health care plan from the Trump administration.
The Lancet: The weaponisation of health care: Using people's need for health care as a weapon of war over six years of Syrian conflict
Marking six years since the start of the Syrian conflict (15 March), a study in The Lancet provides new estimates for the number of medical personnel killed: 814 from March 2011 to February 2017.
In the January Health Affairs: Brazil's primary health care expansion
The January issue of Health Affairs includes a study that explores a much-discussed issue in global health: the role of governance in improving health, which is widely recognized as necessary but is difficult to tie to actual outcomes.
Advocacy and community health care models complement research and clinical care
Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer.
About 1 million Texans gained health care coverage due to Affordable Care Act
Texas has experienced a roughly 6 percentage-point increase in health insurance coverage from the Affordable Care Act, according to new research by experts at Rice University and the Episcopal Health Foundation.
In India, training informal health-care providers improved quality of care
Training informal health-care providers in India improved the quality of health care they offered to patients in rural regions, a new study reports.
Affordable Care Act has improved access to health care, but disparities persist
The Affordable Care Act has substantially decreased the number of uninsured Americans and improved access to health care, though insurance affordability and disparities by geography, race/ethnicity, and income persist.
Integrated team-based care shows potential for improving health care quality, use and costs
Among adults enrolled in an integrated health care system, receipt of primary care at integrated team-based care practices compared with traditional practice management practices was associated with higher rates of some measures of quality of care, lower rates for some measures of acute care utilization, and lower actual payments received by the delivery system, according to a study appearing in the Aug.
Study finds quality of care in VA health care system compares well to other settings
The quality of health care provided to US military veterans in Veterans Affairs (VA) facilities compares favorably with the treatment and services delivered outside the VA.

Related Health Care Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...